• Are Zip Co shares a buy right now?

    Man with a hand on his head looks at a red stock market chart showing a falling share price.

    Zip Co Limited (ASX: ZIP) has always been clear on its trajectory — grow first, make profit later. And for a while, investors were on board with the buy-now-pay-later (BNPL) company’s pathway to profitability. Its cash burn was readily accepted as a means to fuel growth and investors looked to user adoption and transaction volume as the primary measures of success.

    However, with changing economic conditions, investors began asking more questions about execution and profitability.

    What’s happening at Zip Co?

    While Zip Co shares saw circa 60% growth over the last twelve months, year-to-date, they have dropped roughly 40%.

    Zip Co has been responding to changing investor sentiment for some time, reducing costs, improving margins and narrowing losses. In February, it reported some impressive 1H26 results, including:

    • A significant improvement in operating margin at 18.7%, up from 13% on the prior corresponding period (PCP).
    • Record total transaction volume of $8.4 billion, a 34.1% increase on PCP
    • A 4.1% increase in active customers on PCP
    • 10.5% growth in merchants on the platform

    But it is still asking investors to believe that the worst is behind it and the best is still worth waiting for. There is no denying that Zip Co is a company on the improve. The question is whether investors will be willing to back its next phase.

    What is happening in the BNPL sector more broadly?

    Looking at what is happening in the BNPL sector more broadly, it was flying in 2022. In Australia, according to Finder, 49% of Australians were actively using the service to fund purchases. And this looked set to grow. But things went the other way, dropping to 40% or 2 in 5 Australians by 2024. That said, more recent surveys have found high adoption rates amongst younger consumers and Australians remain one of the highest users of BNPL. In addition, with Gen Z eschewing the traditional credit card model, there is still room for user growth.

    Of course, BNPL is irrevocably tied to consumer spending. And it is more widely used by younger consumers, who are also more likely to be affected by current conditions. On the flip side, given that it can fund a wide range of products and services, it may prove an interest-free lifeline on hard-to-delay purchases for some right now.

    Whether you believe BNPL can pick up or not in the current climate is key to your investment decision as reaching profitability for Zip Co is highly sensitive to the broader economic backdrop. 

    Are Zip Co shares a buy right now?

    Many analysts certainly think so. And with the share price rallying 20% yesterday, it looks like investors are starting to agree.

    Zip Co is a materially better business today than it was in 2022. Costs and losses are both trending in the right direction and its geographic footprint is more focused. User growth and transaction volume continue to grow, despite challenging market conditions.

    But right now, Zip Co is sitting in an uncomfortable middle ground. It is no longer a high-growth disruptor that investors are willing to fund on belief alone but has not yet reached profitability. In calmer economic conditions, it could well have remained in investor favour.  

    For me, Zip Co shares are a conditional buy. There is certainly potential upside at the current price. And it is making the right moves towards profitability. But you have to be comfortable with some volatility in near-term and wholeheartedly believe in a cyclical recovery in consumer spending.

    The post Are Zip Co shares a buy right now? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Zip Co right now?

    Before you buy Zip Co shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Zip Co wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Melissa Maddison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Sandfire Resources posts Q3 FY26 operations highlights and maintains guidance

    Cheerful businessman with a mining hat on the table sitting back with his arms behind his head while looking at his laptop's screen.

    The Sandfire Resources Ltd (ASX: SFR) share price is in focus as the company posted group copper equivalent production of 34.5kt for the March quarter, and a net cash balance of $76 million at quarter-end.

    What did Sandfire Resources report?

    • Group copper equivalent (CuEq) production of 34.5kt in Q3 FY26, totalling 106.5kt for the nine months to 31 March 2026
    • MATSA mine produced 21.7kt CuEq in the quarter; Motheo mine delivered 12.8kt CuEq
    • Net cash balance of $76 million as at 31 March 2026, up $63 million from December 2025
    • Group capital expenditure guidance for FY26 reduced by $15 million to $225 million
    • Underlying operating costs: $86/t at MATSA and $44/t at Motheo, in line with guidance

    What else do investors need to know?

    Persistent high rainfall and unplanned maintenance limited MATSA’s output in Q3, while Motheo’s transition to higher grade ore was delayed. However, both mines recorded improvements in annualised ore mining and processing rates, with Motheo achieving a record 6.5Mt mined and 6.1Mt processed.

    The company’s FY26 copper equivalent production guidance remains at 149kt to 165kt, though full-year performance is now expected in the lower half of that range. Guidance for operating costs was reaffirmed, barring extended impacts from the Middle East conflict on freight and energy prices.

    Sandfire also made its inaugural tax payment from Motheo and completed additional payments to Havilah Resources related to its Kalkaroo project. Management’s next in-depth update will come with the full March 2026 Quarterly Report later this month.

    What’s next for Sandfire Resources?

    Looking ahead, Sandfire expects an upswing in production volumes in the June quarter, particularly at Motheo as higher grade ore comes online. The company is aiming to meet the lower half of guidance ranges for both operations in FY26 and is keeping capital spending tightly managed following a slight delay in ramping up activity at Kalkaroo.

    Management says FY26 cost guidance is on track for MATSA and Motheo, although external factors like freight and energy costs remain a watchpoint. Investors can expect a fuller financial and operational update with the upcoming official quarterly report release.

    Sandfire Resources share price snapshot

    Over the past 12 months, Sandfire Resources shares have risen 153%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 21% over the same period.

    View Original Announcement

    The post Sandfire Resources posts Q3 FY26 operations highlights and maintains guidance appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Sandfire Resources NL right now?

    Before you buy Sandfire Resources NL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Sandfire Resources NL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • Transurban Group March quarter 2026: Traffic rises across key toll roads

    Many cars travell on a busy six lane road way with other cars in the background travelling in the opposite direction, going the other way.dway

    The Transurban Group (ASX: TCL) share price is in focus after the company reported a 3.0% increase in average daily traffic (ADT) for the March 2026 quarter, boosted by strong performances in Melbourne and North America.

    What did Transurban Group report?

    • Group average daily traffic up 3.0% to 2,536,000 trips versus Q3 FY25
    • Melbourne ADT grew 3.8%, driven by the opening of the West Gate Tunnel
    • Brisbane ADT increased 5.2%, reflecting post-cyclone recovery
    • North America ADT rose 7.9%, supported by the 495 Northern Extension ramp-up
    • Sydney ADT edged up 0.6% despite ongoing freeway construction impacts

    What else do investors need to know?

    Transurban’s latest quarterly update highlights resilience amid ongoing macroeconomic and geopolitical uncertainty. Major projects like Sydney’s M7 upgrade and the new West Gate Tunnel in Melbourne contributed to traffic growth. The company noted that 90% of its revenue is either CPI-linked or has fixed escalations, helping provide stability during market swings.

    Large vehicle traffic remained a key driver, especially in Melbourne, which saw an impressive 17.1% increase in this category. In North America, the 495 Express Lanes posted a 17.2% jump in ADT, while the 95 Express Lanes delivered steady growth.

    Transurban also stressed its ongoing support for customers through its Linkt Assist program and expanded assistance for community organisations and small suppliers, reflecting its focus on customer and community care.

    What did Transurban Group management say?

    Chief Executive Officer of Transurban Group Michelle Jablko said:

    This quarter’s results reflect the strength of our diversified portfolio and our ability to keep Australia’s cities moving, even during challenging market conditions.

    What’s next for Transurban Group?

    Transurban is looking ahead to the staged opening of widened sections of the Sydney M7 in the June quarter and the anticipated completion of the Warringah Freeway project by the end of 2026. Management will continue to monitor the evolving geopolitical and macroeconomic environment and assess how developments might impact travel patterns and demand.

    With most revenue either linked to inflation or set by contract, the company remains optimistic about its ability to deliver consistent returns and maintain support for customers dealing with cost-of-living pressures.

    Transurban Group share price snapshot

    Over the past 12 months, Transurban shares have risen 3%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 21% over the same period.

    View Original Announcement

    The post Transurban Group March quarter 2026: Traffic rises across key toll roads appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Transurban Group right now?

    Before you buy Transurban Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Transurban Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Transurban Group. The Motley Fool Australia has positions in and has recommended Transurban Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

  • How much can I earn in retirement and still qualify for the Age Pension?

    An older woman gazes over the top of her glasses with a quizzical expression as if she is considering some information.

    The Age Pension is an extra fortnightly payment from the government to help you fund your living expenses in retirement. 

    It’s one of Australia’s most important safety nets which ensures Australians have a minimum income in retirement if their superannuation isn’t enough.

    The problem is, with rising inflation and the cost of food, petrol and mortgage repayments climbing higher and higher, sometimes the Age Pension falls short of retiree’s needs. This means additional income is required to meet living costs.

    However, there’s also a limit to how much income you can bring in retirement to quality for the pension.

    Here’s everything you need to know.

    What’s the retirement income test for the age pension

    Age Pension rates vary wildly for singles and couples, and depend on your assets and any additional income. 

    As of the 20th of March this year, the Age Pension is a maximum of $1,100.30 per fortnight for singles and up to $829.40 per person for couples. This doesn’t include any additional potential supplement rates.

    But the Age Pension is subject to both an income test and an asset test. Unfortunately, Australians in retirement are paid under whatever test that produces the lowest rate of payment.

    The income test assesses all of your income pooled from all sources. That includes anything from superannuation contributions, investment income, part-time wages, bonuses or commission payments. It’s applicable regardless of your age. 

    So how much can I earn?

    As of last month, in order to receive the full Age Pension, singles can’t earn more than $218 per fortnight, and couples can’t earn more than $380 per fortnight.

    But it’s still possible to receive a part pension if you earn over those thresholds.

    Singles can earn up to $2,619.80 per fortnight and couples (living together) can earn up to $4,000.80 per fortnight and still qualify for at least a part-pension. Couples living apart due to ill health can earn a little more, at up to $5,183.60.

    But it’s important to note that earning up to these thresholds will reduce your Age Pension payment. For a single person, your Age Pension will reduce by 50 cents for each dollar over $218 and for couples it will reduce by 25 cents for each dollar over $380.

    How much will retirement actually cost me?

    According to ASFA, a comfortable retirement is expected to cost approximately $54,840 per year for individuals and $77,375 per year for couples.

    That translates to approximately $2,109 per fortnight for singles and around $2,975 per fortnight for couples. 

    The post How much can I earn in retirement and still qualify for the Age Pension? appeared first on The Motley Fool Australia.

    Wondering where you should invest $1,000 right now?

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes could be the ‘five best ASX stocks’ for investors to buy right now. We believe these stocks are trading at attractive prices and Scott thinks they could be great buys right now…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 ASX 200 shares I rate as top buys for growth

    A fit woman in workout gear flexes her muscles with two bigger people flexing behind her, indicating growth.

    S&P/ASX 200 Index (ASX: XJO) shares with a lot of growth potential could be some of the best investments to buy since they’re probably already market leaders in their respective industries, with potential to increase their earnings even further.

    I’m bullish about the two businesses I’m about to talk about. I’ve bought shares for my own portfolio because of what they could achieve between now and 2030.

    When it comes to investing in ASX growth shares, I think it’s a good idea to think at least three to five years ahead. This allows ample time for businesses to execute their plans and initiatives.

    Breville Group Ltd (ASX: BRG)

    Breville is one of the world’s leading coffee machine businesses – it has multiple brands including Breville, Sage, Lelit and Baratza, as well as a coffee bean business called Beanz.

    There are few Australian businesses that have had as much global success as Breville, which continues to deliver excellent double-digit revenue growth.

    In the FY26 half-year result, total global product revenue grew by 10.9% to $973.6 million, with Americas revenue growing 11.6% to $549.5 million, Asia Pacific revenue rising 5.9% to $190.3 million and EMEA (Europe, the Middle East and Asia) revenue rising 13.7% to $233.8 million.

    That growth was achieved despite a challenging operating environment, including US tariffs.

    I think the ASX 200 share can continue growing its global presence, particularly in some of its newer markets like South Korea, China and the Middle East. I also think it will continue to invest in development to create new products to unlock more growth in its existing markets.

    According to the projection on CMC Invest, the ASX share is valued at 26x FY27’s estimated earnings. If the business can grow its net profit by more than 10% per year after FY26, I think it will have a very promising future.

    Guzman Y Gomez Ltd (ASX: GYG)

    GYG is one of the fastest-growing quick service restaurant (QSR) businesses in Australia.

    I think it’s an excellent ASX 200 share to own because both the ongoing sales growth for its existing network, as well as its restaurant rollout plans.

    Its recent FY26 third-quarter update included numerous positive figures, which I think bodes well for the foreseeable future.

    In the three months to 31 March 2026, the business reported that its total network sales grew by 19.5% to $345.9 million, with Australian network sales increasing 19.7% to $320.4 million.

    For me, the success of the Australian division is essential because it’s where a vast majority of the global network is located. Australia is also the market where the company expects its network to grow from 242 to 1,000 over the next 20 years. The 242 locations represented a rise of 14.7% year-over-year.

    Asia is also an exciting market because it’s gaining traction across Singapore and Japan. The combined network of those two countries increased three locations year-over-year to 13 at 31 March 2026, while Asian network sales rose 15% to $21.5 million.

    If the business can continue growing its Australia and Asian network sales by between 15% to 20% per year, I think the ASX 200 share could be a great long-term performer.

    The post 2 ASX 200 shares I rate as top buys for growth appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Guzman Y Gomez right now?

    Before you buy Guzman Y Gomez shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Guzman Y Gomez wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has positions in Breville Group and Guzman Y Gomez. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Where to invest $7,000 in ASX shares during April

    Person pointing at an increasing blue graph which represents a rising share price.

    The ASX share market has seen major volatility since the end of February 2026. There are opportunities worth sniffing out.

    If I had $7,000 to invest in a couple of ideas today, there are a few I’d want to highlight.

    But, the two below are particularly appealing, and I’m calling them buys today.

    Tuas Ltd (ASX: TUA)

    Tuas is a leading ASX telecommunications share that’s based in Singapore, and it’s rapidly expanding its market share in the country.

    In the FY26 half-year result, Tuas reported that its active mobile services increased by 21.5% to 1.41 million, helping revenue grow by 25.5% to $73.2 million, and underlying operating profit (EBITDA) rose by 27.2% (excluding its cost related to the ongoing acquisition of Singapore competitor M1). The company is winning subscribers with its focus on providing great value.

    Thanks to the telco’s operating leverage, the business is seeing its profit margins improve. The underlying EBITDA margin rose from 45% to 46%, meaning that additional revenue dollars are increasingly valuable and can help its bottom line grow at a faster pace, which is a key driver of the Tuas share price.

    The Tuas share price has declined by around 20% since 23 January 2026, making it much better value.

    While the business still has a very small broadband subscriber base, it’s starting to gain some traction there. In HY26, broadband subscribers jumped 220% to 46,133.

    In the next few years, I’m expecting its market share and profit margins to continue to increase as its subscriber base grows, particularly once the M1 acquisition settles and if the ASX share expands into other countries.

    I expect its profits will rise significantly in the coming years under the excellent stewardship of David Teoh.

    VanEck Morningstar Wide Moat ETF (ASX: MOAT)

    Another investment I want to highlight is this exchange-traded fund (ETF) that focuses on quality US businesses.

    One of the main things that keeps a business ahead of others is its competitive advantage (an economic moat), which can take many forms. I’m thinking of things like intellectual property, cost advantages, network effects, brand power, and so on.

    When a competitive advantage allows a business to make good profits year after year, it means they have a strong economic moat.

    The MOAT ETF seeks businesses that Morningstar analysts believe will almost certainly have competitive advantages that last for at least 20 years, giving them excellent longevity to generate strong profits.

    But it’s not just a portfolio of great businesses. Morningstar has judged these businesses to be trading at an attractive valuation, which I think makes them an appealing option for potentially outperforming the local and global share markets.

    According to VanEck, the MOAT ETF has returned an average of 13.6% per year since it started in June 2015.

    The post Where to invest $7,000 in ASX shares during April appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Tuas Limited right now?

    Before you buy Tuas Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Tuas Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has positions in Tuas and VanEck Morningstar Wide Moat ETF. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended VanEck Morningstar Wide Moat ETF. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Is this battered ASX biotech stock ready to rocket higher?

    woman in lab coat conducting testing.

    ASX biotech stock Neuren Pharmaceuticals Ltd (ASX: NEU) finally delivered some good news. Shares jumped 5.7% on Wednesday to $13.00, outpacing the 2.6% gain of the S&P/ASX 200 Index (ASX: XJO).

    This followed the biotech company announcing a new commercial milestone for its flagship Rett syndrome therapy.

    For investors, it was a welcome reprieve. But the ASX biotech stock is still down more than 30% since the start of 2026, leaving some long-term holders wondering if now is the time to step back in.

    A fresh commercial milestone

    A new commercial milestone for Neuren’s lead Rett syndrome therapy DAYBUE drove Wednesday’s lift. Partnered with US biotech giant ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), Neuren confirmed its DAYBUE STIX powder formulation is now widely available across the US.

    The therapy, approved by the US Food and Drug Administration in December, first launched on a limited basis during the March quarter. The expanded rollout means more patients and caregivers now have access to the treatment.

    The powder formulation gives families greater flexibility in dosing and taste as they can mix the powder with water-based liquids. This small change can make a meaningful difference in managing Rett syndrome day to day.

    Increasing royalty income

    Neuren receives royalties on all global net sales of trofinetide under its licensing agreement with ACADIA. Historically, commercial milestones like this one tend to have an immediate impact on the price of the ASX biotech stock.

    At its FY25 results, Neuren reported $65 million in royalty income and expects further growth in 2026 as DAYBUE sales expand. ACADIA has guided for DAYBUE net sales of US$460–490 million this year, implying another strong year of royalty growth for Neuren.

    Strengths and risks

    Neuren’s strengths are clear. Its lead therapy addresses an underserved rare disease market, and the royalty model gives it high-margin, recurring income with minimal operational risk. The broader rollout also demonstrates increasing commercial traction, which can help restore investor confidence.

    That said, risks remain. The fortunes of the ASX biotech stock are tightly linked to ACADIA’s commercial execution. Any delays, pricing pressures, or regulatory hurdles could weigh on revenue.

    The company also operates in the volatile biotech sector, where investor sentiment can swing sharply on clinical or regulatory news.

    Analyst snapshot

    Bell Potter remains bullish. The broker recently reaffirmed its buy rating and $22.00 price target. At the current share price of $13.00, this implies potential upside of roughly 70% over the next 12 months.

    TradingView data show that brokers are upbeat on the ASX biotech stock. The most bullish average 12-month price target is $29.00, which points to a 123% upside, while the most conservative forecast comes in at $18.40. That still suggests a potential gain of 41%.

    Foolish Takeaway

    For investors willing to tolerate biotech volatility, Neuren’s recent milestone, strong royalty pipeline, and underappreciated market potential could make this battered ASX biotech stock one to watch closely.

    The post Is this battered ASX biotech stock ready to rocket higher? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Neuren Pharmaceuticals Limited right now?

    Before you buy Neuren Pharmaceuticals Limited shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Neuren Pharmaceuticals Limited wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Why are CSL shares struggling to regain momentum?

    young female doctor with digital tablet looking confused.

    CSL Ltd (ASX: CSL) shares climbed 1.33% on Wednesday, to end the day at $142.18 a piece. Over the past five days the Australian biotech stock has climbed nearly 1% higher.

    The past few days might look like a step in the right direction, but the reality is that it doesn’t even make a pinprick in terms of recovering the huge losses made over the past couple of years. 

    CSL shares spiked at a 18-month high back in July 2024, and since then it’s been a consistent string of declines. The share price is now 41% lower than 12 months ago, and down 17% for the year-to-date.

    The most interesting thing is that analysts have widely considered the biotech company’s shares oversold and undervalued for some time now. 

    TradingView data shows that 12 out of 18 analysts have a buy or strong buy rating on the shares, with a maximum upside of $268.67. That implies a 89% upside as of the close of the ASX on Wednesday afternoon.

    The headwinds the company has faced over the past 18 months look to be easing, there is significant and recurring global demand for its biotherapy products, and limited competition in the space.

    The company is also growing, with some periods of double‑digit profit growth, and forecasts which underpin a recovery over the long term.

    So why is it that CSL shares are struggling to regain the momentum? 

    It looks like the problem could mostly be two-fold.

    1. Investors lost confidence

    A key reason behind why CSL shares are struggling to come back, is that there has been a major shift in investor sentiment.

    CSL was once widely viewed as one of the most dependable growth companies on the ASX. But over the past few years it has experienced a notable slowdown in earnings growth and a sharp share price reduction. There have also been operational challenges and other headwinds such as lower vaccine demand, a surprise restructure, and even shock CEO exit.

    In short, the company lost its reputation as a reliable ASX stock. Investors are no longer willing to pay a premium without a strong pipeline of expansion or concrete proof that share price growth can return.

    2. There has been a market rotation

    At the same time as the company-specific headwinds, there has been a broad market rotation away from healthcare related stocks so far in 2026. 

    ASX healthcare shares have lagged behind most other sectors on the index so far in 2026 as investors reposition themselves towards ASX energy stocks, resources, and defensive assets. 

    This rotation has put further pressure on CSL shares, and has prevented a meaningful recovery in the company’s valuation.

    What will it take for CSL shares to finally bounce back?

    Ultimately, CSL might not gain positive traction from investors until it can prove that it has reignited short-term revenue and profit growth and overcome hurdles faced over the past 18 months.

    Once investor sentiment shifts it could spark a sharp uptick in interest in its shares.

    And of course, a market-wide rotation back towards healthcare stocks would also help.

    The post Why are CSL shares struggling to regain momentum? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in CSL right now?

    Before you buy CSL shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and CSL wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Are Zip shares still a buy after soaring 20%

    A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.

    Zip Co Ltd (ASX: ZIP) share flew 20% higher on Wednesday, closing the day at $1.99 a piece.

    The price hike marks a turnaround for the Australian financial technology company’s shares after they plunged 19% in March alone.

    The latest trading price means Zip shares are now down 41% for the year-to-date, but a huge 57% higher than this time 12 months ago.

    The fintech company delivered a record result in February but missed expectations. Zip’s revenue margin declined 7.9%, net bad debts increased slightly to 1.73% of TTV. Zip also said it expected its second-half cash EBITDA is expected to be broadly in line with the first half. 

    Investors were spooked by concerns about rising competition, slowing growth and margin compression and it caused a sharp sell-off.

    It’s just one of many headwinds which has faced the business over the past six months. The stock faced pressure from short sellers in late-2025, and investors taking their gains off the table after a huge mid-year price rally.

    As a tech company, Zip has also been caught up in the recent sector-wide tech sell off. Rising concerns about the global impact of the war in the Middle East drove investors away from high-growth technology stocks and towards more stable assets.

    What caused the mid-week Zip share price rally?

    There hasn’t been any price sensitive news out of the fintech company recently to explain the sudden price surge. It’s likely that the price hike is due to a combination of factors.

    I’d expect that a major theme driving the share price higher is investors buying back into the stock amid a shift in sentiment. Analysts widely consider the tech stock to be undervalued and oversold, and it looks like investor sentiment has finally caught up.

    Meanwhile, news that US President Donald Trump has reached a ceasefire agreement with Iran has renewed hopes that the Middle East conflict could resolve. As a result, we saw large gains across many sectors on the ASX on Wednesday, technology included. 

    There are great growth prospects for Zip this year which may also have boosted sentiment. In February, the company announced it is aggressively expanding its US presence by launching its new Pay in 2 product. Its US business now drives over 75% of its total translation volume. The new product allows consumers to split a purchase into two instalments paid over two weeks.

    Zip is also pursuing a dual sharemarket listing on the Nasdaq in the US. This could potentially drive opportunity for business expansion.

    How high can Zip shares go?

    Last month I predicted that the buy-now-pay-later (BPNL) provider’s shares could explode higher this year. Even after Wednesday’s share price spike, Zip shares look like a bargain.

    Analysts agree, and TradingView data shows all 11 analysts with a rating on the stock hold a consensus buy rating on Zip shares. 

    The average target price is $4.04, which implies a potential 102% upside at the time of writing. Others still think the stock could soar even higher, up another 164% to $5.27 within the next 12 months!

    The post Are Zip shares still a buy after soaring 20% appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Zip Co right now?

    Before you buy Zip Co shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Zip Co wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Samantha Menzies has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Up 125% and at record high, can this ASX gold stock keep soaring?

    A golden woman shoots a bow and arrow high.

    This ASX gold stock is on fire.

    Greatland Resources Ltd (ASX: GGP) shares finished 13% higher to $15.23 on Wednesday afternoon, after earlier hitting a fresh all-time high of $15.32 before some profit-taking kicked in.

    Even with that pullback, the numbers are eye-catching. The ASX gold stock is up roughly 45% in 2026 and more than 125% since it was listed on the ASX in June last year.

    So, what’s driving the latest surge and is there more to come?

    Strong gold production and cash boost

    Let’s start with production. In its March quarter update, Greatland delivered 82,723 ounces of gold and 4,128 tonnes of copper from Telfer. But sales were even stronger, hitting 97,800 ounces of gold and 4,620 tonnes of copper.

    That translated into serious cash generation.

    The company’s cash balance jumped to $1.208 billion at 31 March, up from $948 million just three months earlier. That’s a $260 million boost, even after capital spending and a $73 million tax bill tied to the Telfer acquisition.

    And here’s the kicker: no debt. That leaves the ASX gold stock in a powerful position to fund growth across the Paterson region without financial strain.

    No fuel disruptions

    Another factor that’s boosting sentiment around the ASX gold stock? Operational stability.

    Management highlighted that Telfer is largely insulated from Middle East fuel disruptions. Diesel is secured under long-term contracts via Port Hedland, while power comes from Pilbara gas infrastructure.

    In a volatile global environment, that kind of reliability matters.

    Then there’s the gold price. With gold trading near record levels, miners like Greatland are benefiting from strong margins and clear earnings visibility. That’s helping drive investor confidence.

    What next for the ASX gold stock?

    Looking ahead, the outlook remains strong.

    Production is tracking slightly above the upper end of FY26 guidance, which sits between 260,000 and 310,000 ounces of gold. That suggests a strong finish to the year and helps explain why buyers are piling in for the ASX gold stock.

    This follows a solid first-half result, where Greatland posted $977.3 million in revenue and $342.9 million in net profit.

    But it’s not all smooth sailing. Gold miners are still exposed to commodity price swings. If gold prices pull back, earnings could come under pressure. There are also the usual risks around operations, costs, and project execution.

    Still, analysts are turning more bullish.

    Citi recently upgraded Greatland to a buy rating, lifting its price target to $16.00 following strong drilling results at Telfer.

    And the bulls see even more upside. The most optimistic forecasts sit around $19.00, implying potential gains of roughly 25% from current levels.

    Foolish Takeaway

    The $9 billion ASX gold stock has momentum and the numbers to back it up.

    With strong production, surging cash flow, and record gold prices, this ASX miner is firing on all cylinders.

    The big question now: how much higher can it go?

    The post Up 125% and at record high, can this ASX gold stock keep soaring? appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Greatland Resources right now?

    Before you buy Greatland Resources shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Greatland Resources wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 20 Feb 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Marc Van Dinther has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.